A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working
Over the past few months, about 30 people who suffer from Lambert-Eaton myasthenic syndrome, or LEMS, have switched back to an older treatment.
No hay comentarios:
Publicar un comentario